Senti Biosciences Holdings, Inc. SNTI
0.16 USD 0.00 (-2.79%)
At closeNov 6, 2026, 7:16 PM EST
0.16 0.00 -2.00%
After hours · Nov 6, 7:16 PM ET
0.1574 Day range 0.1657
0.16 52-week range 2.39
- YTD
- -84.62%
- 1 year
- -91.16%
Financial health
Altman Z-Score
-20.89 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.4×
FY 2019 5y median -0.4× FY 2025
P/S 10629×
FY 2019 5y median 18.9× FY 2025
P/B 41.8×
FY 2019 5y median 0.6× FY 2025
P/FCF -5.4×
FY 2019 5y median -0.8× FY 2025
EV/EBITDA -4.3×
FY 2019 5y median -0.9× FY 2025
EV/Sales 11195×
FY 2019 5y median 15.7× FY 2025
FCF Yield -18.7%
FY 2019 5y median -123.1% FY 2025
Profitability
Gross Margin -16431.8%
FY 2019 5y median 100.0% FY 2025
Operating Margin -289668.2%
FY 2019 5y median -1889.3% FY 2025
Net Margin -279263.6%
FY 2019 5y median -2414.6% FY 2025
ROE -1099.3%
FY 2019 5y median -106.2% FY 2025
ROIC -149.7%
FY 2019 5y median -68.2% FY 2025
ROA -119.9%
FY 2019 5y median -57.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -4.4%
FY 2019 FY 2025
EPS (diluted) 76.2%
FY 2019 FY 2025
Free Cash Flow -5.4%
FY 2019 FY 2025
Financial Health
Current Ratio 1.7×
FY 2019 5y median 4.5× FY 2025
Quick Ratio 1.7×
FY 2019 5y median 4.5× FY 2025
Debt / Equity 5.2×
FY 2019 5y median 0.6× FY 2025
Net Debt / EBITDA -0.2×
FY 2019 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31